A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory ...

Gendered racial microaggressions during obstetric care were associated with elevated blood pressure among postpartum ...

Heterosexual midlife women veterans reported more sexual dysfunction and impact from vaginal symptoms and were less likely to ...

Results published in the American Journal of Sports Medicine showed surgical delays of more than 4 months may increase the ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

The FDA granted rare pediatric disease designation to VG901 for the treatment of retinitis pigmentosa caused by mutations in ...

No link was found between Competitive Bidding Program implementation and changes in supplemental oxygen use or clinical ...